VetWatch reports lower vaccine and parasite-control spending. Vetsource’s US sample averaged fewer new puppy and kitten patients per practice in 2025. This edition also covers approval of Convenia RTU for Dogs, a survey on staff stress and an Accuplex test comparison. The focus is local demand, staff time and full costs before changing orders, services or tests.
US surveys show more dog-owning and cat-owning homes. Average household pet spending fell. Vetsource reports fewer patients with recorded preventive purchases. This edition covers stock plans, graduate job offers, Previcox packs and Instinct’s dashboard. Maven’s assistant is an early watch item, it could change app use and clinic questions.
Synchrony, Antech and Instinct announced links for clinic payments, test results and imaging reports. Digitail’s survey found that some users still move data by hand. Cronus announced US distribution of Florfinasone Otic for certain outer ear infections in dogs. This edition focuses on full task times, software limits and buying costs before clinics change systems or orders.
Comments on US animal vaccine rules close October 13. Elanco reports more Credelio Quattro clinics, while Vetoquinol reports higher US sales across all species. CUBEX launched a cabinet to track medicine use. Cat owners spent more on food on average in 2025. This edition's focus is repeat sales, staff time and stock costs before changing orders or forecasts.
Chewy added debt as it spent on acquisitions, new sites and share buybacks. Petco’s product sales fell as services and other revenue grew. This edition also covers Fi’s recall of two dog supplement lots, screwworm prevention uses and updated kidney care guidance for cats. The focus is orders, clinic earnings and the costs of stock, staff and growth.
US FDA proposed an animal-drug compounding policy for registered facilities, while Vetsource reported deeper declines in visits, product revenue and preventive dispensing. This PULSE edition also covers canine diabetes guidance, staff-reported care-decline thresholds, a bedinvetmab X-ray pattern in selected safety reports and Vet Intel’s acquisition of Antelligence.
PetMeds reported a 19.9% net sales fall and lower cash. Simparica TRIO received FDA emergency authorization to treat screwworm in dogs, while language models missed cases surgeons classified for surgery. This edition also covers IDEXX’s planned Cancer Dx additions, Battery Ventures’ Vetspire investment and copyright suits alleging unlicensed image use by veterinary practices.
Two US practice data samples showed more revenue while visit, client, invoice or patient counts fell. US pet insurers wrote more direct premiums in 2025; Merck and Hill’s global sales rose in the second quarter. American Regent recalled 2 Adequan Canine lots after it found glass fibers.
Tractor Supply plans to close about 75 Petsense stores, and Central Garden & Pet agreed to buy about 80% of TRIXIE. Mexico’s screwworm certificate rule starts August 3, and Vermont approved entry controls; Royal Canin expanded Amazon access. This edition also covers customer stock cuts, a delayed launch shipment and 3 recalled cyclophosphamide lots.
CVS pages conflicted on pet-prescription availability, and Texas added three screwworm zones and revised Zone 14.A. This edition also covers FDA animal-drug manufacturing incentives, Four Corners’ purchase of 102 Mission-operated properties, and Virbac companion animal growth alongside lower total North American revenue.
Revenue rose while patient counts and preventive purchases fell. Zoetis agreed to buy VitalRADS, and Bond Vet and Small Door completed their merger. This edition also covers Royal Canin’s fresh therapeutic dog diets, the PetMeds–Rural King online pharmacy, and an FDA proposal for shared registration across linked drug-making sites.
Revenue rose while clients, patients and key purchases fell this week. This edition also covers OpenVet’s public beta and clinic AI rules, FDA and Pedigree product-record updates, General Mills pet sales with lower organic sales, and MiDOG’s parasite-only test for unresolved parasite cases. The early watch item tracks whether Waltham FelQoL moves from research use into feline visit forms, client reports or nutrition materials.
